U.S. Food, 2017-11-28: FDA's original 2017 safety communication warning that high-dose biotin, including supplements marketed for hair, skin and nail growth, can cause falsely high or falsely low lab results, including falsely low troponin.
The FDA has seen an increase in the number of reported adverse events, including one death, related to biotin interference with lab tests.
'Summary of Problem and Scope'
U.S. Food, 2017-11-28: FDA's original 2017 safety communication warning that high-dose biotin, including supplements marketed for hair, skin and nail growth, can cause falsely high or falsely low lab results, including falsely low troponin. Study type: regulatory record.
